ScholarIQanswers from OpenAlex
Computational Drug Discovery Methods
TopicLeading institutions, researchers & key papers
Computational Drug Discovery Methods is a topic indexed in ScholarIQ from OpenAlex.
What is known about Computational Drug Discovery Methods?
ScholarIQrecord summary
This cluster of papers focuses on computational methods, virtual screening, and molecular docking techniques used in drug discovery. It covers topics such as drug target identification, pharmacokinetics, chemical properties, machine learning applications, polypharmacology, and network pharmacology.
How many works does Computational Drug Discovery Methods have?
ScholarIQindexed works
Computational Drug Discovery Methods has 201 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Computational Drug Discovery Methods?
ScholarIQopenalex
The OpenAlex for Computational Drug Discovery Methods is on the source record.
What are the most-cited papers on Computational Drug Discovery Methods?
ScholarIQmost cited works
DrugBank 6.0: the DrugBank Knowledgebase for 2024
Craig Knox, Mike Wilson, Christen M. Klinger, Mark Franklin, Eponine Oler, Alexander E. Wilson, Allison Pon, Jordan J. Cox, Na Eun Chin, Seth A Strawbridge, Marysol García-Patiño, Ray Kruger, Aadhavya Sivakumaran, Selena Sanford, Rahil Doshi, Nitya Khetarpal, Omolola Fatokun, Daphnee Doucet, Ashley Zubkowski, Dorsa Yahya Rayat, Hayley Jackson, Karxena Harford, Afia Anjum, Mahi Zakir, Fei Wang, Siyang Tian, Brian Lee, Jaanus Liigand, Harrison Peters, Ruo Qi Wang, Tue Nguyen, Denise So, Matthew Sharp, Rodolfo da Silva, C. Gabriel, J.D. Scantlebury, Marissa Jasinski, David S. Ackerman, Timothy Jewison, Tanvir Sajed, Vasuk Gautam, David S. Wishart
Alzheimer's disease: clinical trials and drug development
Francesca Mangialasche, Alina Solomon, Bengt Winblad, Patrizia Mecocci, Miia Kivipelto
Seven Golden Rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry
Tobias Kind, Oliver Fiehn
Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
Marina Sirota, Joel T. Dudley, Jeewon Kim, Annie Chiang, Alex A. Morgan, E. Alejandro Sweet‐Cordero, Julien Sage, Atul J. Butte
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Harald Hampel, Richard Frank, Karl Broich, Stefan Teipel, Russell Katz, John Hardy, Karl Herholz, Arun L.W. Bokde, Frank Jessen, Yvonne C. Hoessler, Wendy R. Sanhai, Henrik Zetterberg, Janet Woodcock, Kaj Blennow
Where is Computational Drug Discovery Methods research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Computational Drug Discovery Methods is open access?
ScholarIQopen access share
60%OPEN ACCESS